Cargando…

Mitochondrial disease registries worldwide: A scoping review

BACKGROUND: Mitochondrial diseases are a large group of genetically heterogeneous and clinically diverse disorders. Diagnosis often takes many years for which treatment may not exist. Registries are often used to conduct research, establish natural disease progression, engage the patient community,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul-Fatah, Ammanie, Esmaeilisaraji, Leila, Juan, Crisel Mae, Holcik, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612561/
https://www.ncbi.nlm.nih.gov/pubmed/36301904
http://dx.doi.org/10.1371/journal.pone.0276883
_version_ 1784819800226136064
author Abdul-Fatah, Ammanie
Esmaeilisaraji, Leila
Juan, Crisel Mae
Holcik, Martin
author_facet Abdul-Fatah, Ammanie
Esmaeilisaraji, Leila
Juan, Crisel Mae
Holcik, Martin
author_sort Abdul-Fatah, Ammanie
collection PubMed
description BACKGROUND: Mitochondrial diseases are a large group of genetically heterogeneous and clinically diverse disorders. Diagnosis often takes many years for which treatment may not exist. Registries are often used to conduct research, establish natural disease progression, engage the patient community, and develop best disease management practices. In Canada, there are limited centralized registries for mitochondrial disease patients, presenting a challenge for patients and professionals. OBJECTIVE: To support the creation of such a registry, a systematic scoping review was conducted to map the landscape of mitochondrial disease patient registries worldwide, with a focus on registry design and challenges. Furthermore, it addresses a knowledge gap by providing a narrative synthesis of published literature that describes these registries. METHODS: Arksey and O’Malley’s methodological framework was followed to systematically search English-language literature in PubMed and CINAHL describing the designs of mitochondrial disease patient registries, supplemented by a grey literature search. Data were extracted in Microsoft Excel. Stakeholder consultations were also performed with patient caregivers, advocates, and researchers to provide perspectives beyond those found in the literature. These data were thematically analyzed and were reported in accordance with the PRISMA-ScR reporting guidelines. RESULTS: A total of 17 articles were identified describing 13 unique registries located in North America, Europe, Australia, and West Asia. These papers described the registries’ designs, their strengths, and weaknesses, as well as their tangible outcomes such as facilitating recruitment for research and supporting epidemiological studies. CONCLUSION: Based on our findings in this review, recommendations were formulated. These include establishing registry objectives, respecting patients and their roles in the registry, adopting international data standards, data evaluations, and considerations to privacy legislation, among others. These recommendations could be used to support designing a future Canadian mitochondrial disease patient registry, and to further research directly engaging these registries worldwide.
format Online
Article
Text
id pubmed-9612561
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-96125612022-10-28 Mitochondrial disease registries worldwide: A scoping review Abdul-Fatah, Ammanie Esmaeilisaraji, Leila Juan, Crisel Mae Holcik, Martin PLoS One Research Article BACKGROUND: Mitochondrial diseases are a large group of genetically heterogeneous and clinically diverse disorders. Diagnosis often takes many years for which treatment may not exist. Registries are often used to conduct research, establish natural disease progression, engage the patient community, and develop best disease management practices. In Canada, there are limited centralized registries for mitochondrial disease patients, presenting a challenge for patients and professionals. OBJECTIVE: To support the creation of such a registry, a systematic scoping review was conducted to map the landscape of mitochondrial disease patient registries worldwide, with a focus on registry design and challenges. Furthermore, it addresses a knowledge gap by providing a narrative synthesis of published literature that describes these registries. METHODS: Arksey and O’Malley’s methodological framework was followed to systematically search English-language literature in PubMed and CINAHL describing the designs of mitochondrial disease patient registries, supplemented by a grey literature search. Data were extracted in Microsoft Excel. Stakeholder consultations were also performed with patient caregivers, advocates, and researchers to provide perspectives beyond those found in the literature. These data were thematically analyzed and were reported in accordance with the PRISMA-ScR reporting guidelines. RESULTS: A total of 17 articles were identified describing 13 unique registries located in North America, Europe, Australia, and West Asia. These papers described the registries’ designs, their strengths, and weaknesses, as well as their tangible outcomes such as facilitating recruitment for research and supporting epidemiological studies. CONCLUSION: Based on our findings in this review, recommendations were formulated. These include establishing registry objectives, respecting patients and their roles in the registry, adopting international data standards, data evaluations, and considerations to privacy legislation, among others. These recommendations could be used to support designing a future Canadian mitochondrial disease patient registry, and to further research directly engaging these registries worldwide. Public Library of Science 2022-10-27 /pmc/articles/PMC9612561/ /pubmed/36301904 http://dx.doi.org/10.1371/journal.pone.0276883 Text en © 2022 Abdul-Fatah et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Abdul-Fatah, Ammanie
Esmaeilisaraji, Leila
Juan, Crisel Mae
Holcik, Martin
Mitochondrial disease registries worldwide: A scoping review
title Mitochondrial disease registries worldwide: A scoping review
title_full Mitochondrial disease registries worldwide: A scoping review
title_fullStr Mitochondrial disease registries worldwide: A scoping review
title_full_unstemmed Mitochondrial disease registries worldwide: A scoping review
title_short Mitochondrial disease registries worldwide: A scoping review
title_sort mitochondrial disease registries worldwide: a scoping review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612561/
https://www.ncbi.nlm.nih.gov/pubmed/36301904
http://dx.doi.org/10.1371/journal.pone.0276883
work_keys_str_mv AT abdulfatahammanie mitochondrialdiseaseregistriesworldwideascopingreview
AT esmaeilisarajileila mitochondrialdiseaseregistriesworldwideascopingreview
AT juancriselmae mitochondrialdiseaseregistriesworldwideascopingreview
AT holcikmartin mitochondrialdiseaseregistriesworldwideascopingreview